No. A D&C is not required after every miscarriage. Many early pregnancy losses resolve without surgery through expectant management (waiting) or medication. Whether you need a D&C depends on gestational age, how much tissue remains, bleeding and infection risk, and your preferences. Surgery is one of three standard options, not a default.

The obstetric D&C — dilation and curettage, now often called uterine aspiration or surgical evacuation — has a long history as the fastest, most complete way to clear the uterus. Modern guidance treats it as one path among several, chosen for clinical need and patient choice rather than routine. Knowing why that changed requires understanding what the procedure does, what the alternatives do, and where the evidence still supports going straight to the operating room.

What a D&C actually does mechanically

A D&C removes pregnancy tissue from the uterus by opening the cervix (dilation) and scraping or suctioning the lining (curettage). In modern practice, first-trimester evacuation usually relies on suction aspiration, sometimes with sharp curettage to confirm the cavity is empty.

The mechanism matters because retained tissue is the problem the procedure solves. After a loss, the uterus must expel the gestational sac and decidual tissue. When it does not, retained products of conception can keep the cervix open and the uterus contracting irregularly. That sustained bleeding and open cervical canal create the pathway for endometritis, a uterine infection.

Expectant management relies on the same physiology without instruments: falling progesterone destabilizes the pregnancy, the decidua breaks down, and uterine contractions expel the tissue. Medication mimics this by making the uterus contract and the cervix soften. A D&C simply completes in minutes what the body may take days to weeks to finish.

How often each route succeeds

Success rates depend heavily on gestational age and how success is defined. For early losses, expectant management succeeds in roughly half to two-thirds of cases within one to two weeks. Medication with misoprostol raises completion into the range of most cases, with higher success at earlier gestations. Surgical evacuation has the highest single-procedure completion rate, typically above 95 percent in skilled hands.

Speed differs as much as success. Expectant management can take one to two weeks or longer; medication usually acts within one to three days with bleeding lasting about one to two weeks; surgical evacuation empties the uterus immediately. The trade-off is straightforward: less intervention means more waiting and more unpredictability, while surgery means procedural risk in exchange for speed and completeness.

Bleeding volume follows the same pattern. Expectant and medical routes typically produce heavier, longer bleeding than surgery, which often settles within days. That difference matters for people with anemia, low blood pressure, or limited access to urgent care.

Approach Typical completion Time to complete Bleeding duration Procedural risk
Expectant (waiting) Roughly half to two-thirds within 1–2 weeks Days to weeks Often 1–2 weeks Lowest procedural risk; unpredictable
Medication (misoprostol) Most cases, higher at early gestation 1–3 days About 1–2 weeks Cramping, incomplete passage, need for follow-up
Surgical D&C or aspiration Above 95 percent Immediate Usually days Perforation, infection, adhesions, anesthesia risk
Repeat procedure after any route Uncommon but real Varies Varies Depends on initial method

The numbers overlap because "success" is defined differently across studies — empty uterus on ultrasound versus no further intervention versus patient-reported resolution. No single figure applies to every patient.

Why the recommendation changed over time

Before ultrasound became routine, clinicians could not reliably tell whether the uterus was empty. Surgery was the only way to be sure, and infection risk from retained tissue was high enough that prompt evacuation was standard.

Transvaginal ultrasound changed the calculus. It lets clinicians measure retained tissue directly and watch for resolution. Landmark trials in the 2000s compared expectant, medical, and surgical management and found no major safety difference for clinically stable patients. Guidelines from major obstetric bodies subsequently endorsed offering all three options, with surgery reserved for instability, infection, heavy bleeding, or patient preference.

The counterintuitive detail: in clinically stable patients, expectant management is not more dangerous than surgery — it is less invasive, with comparable infection and transfusion risk in trial settings. The exception is when bleeding is heavy or infection is already present, where waiting becomes the risk.

Edge cases that change the answer

Gestational age is the biggest modifier. Losses before about 8 to 10 weeks are more likely to resolve without surgery; later first-trimester losses involve more tissue and higher failure rates for expectant management.

Incomplete miscarriage — some tissue passed, some retained — often responds to medication or a D&C, though expectant management remains an option if bleeding is controlled. Missed miscarriage, where the pregnancy stopped developing but tissue has not passed, tends to need more time with expectant management and has higher failure rates.

Second-trimester loss, molar pregnancy, and suspected gestational trophoblastic disease usually call for surgical evacuation because tissue must be examined and complete removal matters. Cesarean scar ectopic pregnancy and certain uterine anomalies require individualized surgical planning.

Clinical stability is the gate. Heavy bleeding, fever, foul discharge, or hemodynamic instability push toward prompt evacuation regardless of preference.

Practical actions and thresholds

Decide with your clinician based on stability, gestational age, and preference. Ask specifically which option fits your situation and why.

Red flag: soaking a pad or more per hour for two hours, or passing clots larger than a golf ball — seek urgent care. Red flag: fever at or above 100.4°F (38°C), chills, or foul-smelling discharge — possible infection, urgent evaluation. Red flag: dizziness, fainting, or racing heart — possible significant blood loss. Red flag: severe abdominal pain that does not ease with cramping — evaluate for ectopic pregnancy or infection. Follow-up: confirm completion with ultrasound or serial hCG testing per your clinician's plan, since incomplete passage can occur with any route. Ask about Rh status; Rh-negative patients typically need anti-D immune globulin after loss.

Thresholds here are practical guidance, not individualized medical advice. Your clinician applies them to your history.

Limitations and what remains uncertain

Success rates vary by study design, definition, and population, so treat ranges as context rather than prediction. Access to timely follow-up and urgent care affects safety more than the choice itself in stable patients. Some patients strongly prefer certainty and speed; others prefer avoiding anesthesia and instruments. Guidelines support either when the patient is stable. The one thing guidance does not support is treating D&C as mandatory for every miscarriage.